hotspot -WSS

hotspot

author：fashion 2025-09-27 19:28:16 - browse：22624

Duchenne muscular dystrophy is a devastating disease and, until very recently, was one without much hope. When Hawken Miller was diagnosed at age 5, the physician told his parents to enjoy the time they had with him, as there wouldn’t be much. Over 20 years later, Miller is a journalist and content strategist for CureDuchenne, an organization started by his mother when he was diagnosed, and new treatment is on the horizon.

Last month, the FDA approved a new gene therapy from Sarepta Therapeutics that will provide hope for many patients and families. The new drug, however, has its limitations — it’s only approved for children age 4-5, for example. Miller joined the podcast to discuss how this drug may change lives, what more needs to happen, and what his personal experience has been living with Duchenne.

“For the older boys, we’re running up against the clock a little bit with what we’re able to do and what we’re not able to do,” Miller said. “And if we’re able to try anything that could possibly help, I think most people would like the opportunity to do that.”

The conversation is based off his recent First Opinion, “The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： It costs an awful lot of money to give away a kidney

explore

WSS

The cancer stories no one wants to hear

CDC recommends RSV monoclonal antibody for infants

Late stage cancers on the rise after pandemic delayed screenings

HHS suspends federal funding for EcoHealth Alliance

STAT reporters are Pulitzer Prize finalists for investigative reporting

Lilly’s weekly insulin works as well as daily products, new studies show

Wikipedia

hotspot

explore

As demand for Covid shots wanes, Moderna seeks its next success

How to ethically and practically extend health care to all

Medical records are filled with copy

How to ethically and practically extend health care to all

In Memoriam: Notable people who died in 2023

Ripples from Flovent's discontinuation is killing children with asthma

The cancer drug shortage isn’t new — and neither are the solutions

When waiting feels immoral: Empathy in the emergency department

23andMe had bad news about my health. I wish a person had delivered it

Alnylam reports growth in sales of rare disease treatments

hotspot

Flint parents haunted by uncertainty, fears of lead poisoning

Supreme Court to hear if Covid misinformation is protected speech

Physicians aren't 'burning out.' They're suffering from moral injury

Flint parents haunted by uncertainty, fears of lead poisoning

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

HHS suspends federal funding for EcoHealth Alliance

leisure time

explore

hotspot

Wikipedia